Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2 Pt 1
|
pubmed:dateCreated |
1991-5-1
|
pubmed:abstractText |
One hundred thirty-nine patients with severe alopecia areata (the majority with the subtotal, total, or universalis type) were treated with topical immunotherapy (diphenylcyclopropenone). Patients were initially treated unilaterally; the other side of the scalp served as a control. In 50.4% of the patients the response was either excellent (total regrowth) or satisfactory (subtotal regrowth with only a few remaining bald patches). The most frequent side effects were eczematous reactions with blistering, spreading of the induced contact eczema, and sleep disturbances.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0190-9622
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
24
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
253-7
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:2007671-Administration, Topical,
pubmed-meshheading:2007671-Alopecia Areata,
pubmed-meshheading:2007671-Cyclopropanes,
pubmed-meshheading:2007671-Dermatitis, Contact,
pubmed-meshheading:2007671-Eczema,
pubmed-meshheading:2007671-Humans,
pubmed-meshheading:2007671-Immunotherapy,
pubmed-meshheading:2007671-Recurrence
|
pubmed:year |
1991
|
pubmed:articleTitle |
Treatment of alopecia areata with diphenylcyclopropenone.
|
pubmed:affiliation |
Department of Dermatology, University of Nijmegen, The Netherlands.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Controlled Clinical Trial,
Research Support, Non-U.S. Gov't
|